Search

Author/Creator Clark, Mitchell

1. A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability. Issue 6 (7th December 2021)

Authors:
Bellone, Stefania; Roque, Dana M.; Siegel, Eric R.; Buza, Natalia; Hui, Pei; Bonazzoli, Elena; Guglielmi, Adele; Zammataro, Luca; Nagarkatti, Nupur; Zaidi, Samir; Lee, Jungsoo; Silasi, Dan‐Arin; Huang, Gloria S.; Andikyan, Vaagn; Damast, Shari; Clark, Mitchell; Azodi, Masoud; Schwartz, Peter E.; ...
Journal:
Cancer
Issue:
Volume 128:Issue 6(2022)
Page Start:
1206
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. EP007/#994 Bay 1895344, a novel ATR inhibitor, demonstrates in vivo activity against ATRX altered uterine leiomyosarcoma. (4th December 2022)

Authors:
Harold, Justin; Manavella, Diego; Bellone, Stefania; Siegel, Eric; Hartwich, Tobias; Zammataro, Luca; Mutlu, Levent; Altwerger, Gary; Menderes, Gulden; Ratner, Elena; Huang, Gloria; Clark, Mitchell; Andikyan, Vaagn; Azodi, Masoud; Schwartz, Peter; Alexandrov, Ludmil; Santin, Alessandro
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 3
Page Start:
A51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗